Research Focus

Former Employee. Molecular Pharmacology Program; Non-Stipend SKI

Recent additions – View all

1. Melphalan-mobilized blood stem cell components contain minimal clonotypic myeloma cell contamination

   Journal Article

   Zhou, P.; Zhang, Y.; Martinez, C.; Kalakonda, N.; Nimer, S. D.; Comenzo, R. L.
   Blood (2003)

   Fulltext@MSK | Save
2. Ig V-H and V-L patient-specific PCR: Assessing clonotypic contamination in stem cell components (SCC) mobilized with melphalan in myeloma

   Meeting Abstract

   Zhou, P.; Zhang, Y.; Martinez, C.; Kalakonda, N.; Nimer, S. D.; Comenzo, R. L.
   Blood (2002)

   Fulltext@MSK | Save
3. Results of autologous stem cell transplantation (SCT) following stem cell mobilization with melphalan in myeloma patients

   Meeting Abstract

   Comenzo, R. L.; Costello, S.; Reich, L.; Drake, L.; Zhou, P.; Martinez, C.; Klimek, V.; Kewalramani, T.; Osman, K.; Dhodapkar, M.; more...
   Blood (2002)

   Fulltext@MSK | Save